EINDHOVEN, The Netherlands and
TAMPA, Fla., March 19, 2015 /PRNewswire/ -- Royal Philips
(NYSE:PHG, AEX:PHIA) and Inspirata, Inc. today announced that they
have entered into a joint development agreement to advance digital
pathology through the development of advanced image analytics and
automated workflows available as a Solution-as-a-Service delivery
model. Focusing initially on the needs of U.S. cancer centers, the
creation of improved insights and algorithms will help pathologists
in better informed decision making.
"The advancement of digital pathology offers pathologists the
opportunity for improved working experience that can be an
important next step toward improving diagnosis and better and more
accurate treatment," said Perry van Rijsingen, general manager of
Philips Digital Pathology Solutions. "Reducing the investment
required by institutions – particularly high-volume, high-touch
ones like cancer centers – opens the door for more patients to
benefit from this level of care and attention."
Built on the foundation of Philips' innovation and experience in
clinical informatics, Inspirata's managed service model will supply
the necessary IT infrastructure, services and resources for a
digital program and eliminate capital expenditures related to the
transition.
"Infrastructure requirements for digital pathology are
enormous," said Satish Sanan,
Chairman and CEO of Inspirata. "We're talking petabytes of data,
which can exceed the storage requirements of all other clinical
systems combined. Removing this impediment by integrating
everything needed for accelerated department-wide implementation
and long-term support encourages the adoption of professional
services to operationalize and sustain a highly functional digital
pathology environment."
Philips (Booth #502) and Inspirata (Booth #501) will both be
exhibiting at the 2015 USCAP Annual Conference in Boston, taking place March 21-27. For more information, stop by the
booth or visit
http://www.research.philips.com/initiatives/digitalpathology/.
For further information, please contact:
Hans Driessen, Corporate Communications
Philips Digital Pathology Solutions
Tel: +31 6 10 610 417,
E-mail: hans.driessen@philips.com
Marjorie Bulone
Inspirata, Inc.
Tel: 727 215 8141
E-mail: mbulone@inspirata.com
About Inspirata, Inc.
Inspirata, Inc. provides a
cancer diagnostics solution that digitizes and automates the entire
pathology workflow using a unique, "solution as a service" delivery
model. This comprehensive solution includes workflow automation and
computer-aided cancer detection and diagnostic tools. Inspirata's
solution also includes a suite of algorithms to extract relevant
image-based information from digitized histology specimens for use
as supplemental aids to assist pathologists with diagnoses and to
aid in the prediction of disease progression and therapeutic
responses. For more information, please visit www.inspirata.com or
contact info@inspirata.com.
About Royal
Philips:
Royal Philips
(NYSE: PHG, AEX: PHIA) is a diversified health and well-being
company, focused on improving people's lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and
Lighting. Headquartered in the
Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately
105,000 employees with sales and services in more than 100
countries. The company is a leader in cardiac care, acute care and
home healthcare, energy efficient lighting solutions and new
lighting applications, as well as male shaving and grooming and
oral healthcare. News from Philips is located at
www.philips.com/newscenter.
Logo -
http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-and-inspirata-inc-partner-to-bring-an-end-to-end-digital-pathology-workflow-to-us-cancer-centers-300051650.html
SOURCE Royal Philips